Roche新的快速性传染感染测试得到FDA的批准,加快了紧急护理环境的诊断和治疗。 Roche's new rapid STI test gets FDA approval, speeding up diagnosis and treatment in urgent care settings.

罗氏已获得FDA的批准,用于其cobas® liat性传播感染测试,允许在紧急护理和零售诊所等环境中对克拉米迪亚和淋病等感染进行点诊断. Roche has received FDA clearance for its cobas® liat STI test, allowing point-of-care diagnosis of infections like chlamydia and gonorrhea in settings such as urgent care and retail clinics. 测试在20分钟内提供结果,目的是改善获得准确诊断的机会,减少性传播感染的蔓延。 The test, which provides results in 20 minutes, aims to improve access to accurate diagnostics and reduce the spread of STIs. 最初在美国提供,它将有助于更快的治疗和更好的健康结果。 Initially available in the U.S., it will help in faster treatment and better health outcomes.